BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goossens J, Bailly C. Ursodeoxycholic acid and cancer: From chemoprevention to chemotherapy. Pharmacology & Therapeutics 2019;203:107396. [DOI: 10.1016/j.pharmthera.2019.107396] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
Number Citing Articles
1 Borella F, Carosso AR, Cosma S, Preti M, Collemi G, Cassoni P, Bertero L, Benedetto C. Gut Microbiota and Gynecological Cancers: A Summary of Pathogenetic Mechanisms and Future Directions. ACS Infect Dis 2021;7:987-1009. [PMID: 33848139 DOI: 10.1021/acsinfecdis.0c00839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Chen W, Hu D, Feng Z, Liu Z. An effective synthesis of ursodeoxycholic acid from dehydroepiandrosterone. Steroids 2021;172:108870. [PMID: 34038744 DOI: 10.1016/j.steroids.2021.108870] [Reference Citation Analysis]
3 Sönmezgöz E, Takci S, Gül A, Uysal M. Ursodeoxycholic acid protects neonatal rats from necrotizing enterocolitis: a biochemical, histopathological, and immunohistochemical study. J Matern Fetal Neonatal Med 2020;:1-7. [PMID: 32954879 DOI: 10.1080/14767058.2020.1818210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Yao Z, Zhang X, Zhao F, Wang S, Chen A, Huang B, Wang J, Li X. Ursodeoxycholic Acid Inhibits Glioblastoma Progression via Endoplasmic Reticulum Stress Related Apoptosis and Synergizes with the Proteasome Inhibitor Bortezomib. ACS Chem Neurosci 2020;11:1337-46. [PMID: 32239921 DOI: 10.1021/acschemneuro.0c00095] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
5 Liang J, Shao W, Liu Q, Lu Q, Gu A, Jiang Z. Single Cell RNA-Sequencing Reveals a Murine Gallbladder Cell Transcriptome Atlas During the Process of Cholesterol Gallstone Formation. Front Cell Dev Biol 2021;9:714271. [PMID: 34650971 DOI: 10.3389/fcell.2021.714271] [Reference Citation Analysis]
6 Juan C, Zhu Y, Zhou Y, Zhu W, Wang X, He W, Chen Y, Cao S. Exploration of Prognostic Immune-Related Genes and lncRNAs Biomarkers in Kidney Renal Clear Cell Carcinoma and Its Crosstalk with Acute Kidney Injury. Journal of Oncology 2022;2022:1-17. [DOI: 10.1155/2022/6100187] [Reference Citation Analysis]
7 Guzior DV, Quinn RA. Review: microbial transformations of human bile acids. Microbiome 2021;9:140. [PMID: 34127070 DOI: 10.1186/s40168-021-01101-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kumar H, Kumar RM, Bhattacharjee D, Somanna P, Jain V. Role of Nrf2 Signaling Cascade in Breast Cancer: Strategies and Treatment. Front Pharmacol 2022;13:720076. [DOI: 10.3389/fphar.2022.720076] [Reference Citation Analysis]
9 Sun X, Zhang Y, Zhou Y, Lian X, Yan L, Pan T, Jin T, Xie H, Liang Z, Qiu W, Wang J, Li Z, Zhu F, Sui X. NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Res 2021:gkab913. [PMID: 34664659 DOI: 10.1093/nar/gkab913] [Reference Citation Analysis]
10 Navacchia ML, Marchesi E, Perrone D. Bile Acid Conjugates with Anticancer Activity: Most Recent Research. Molecules 2020;26:E25. [PMID: 33374573 DOI: 10.3390/molecules26010025] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Huang TE, Deng YN, Hsu JL, Leu WJ, Marchesi E, Capobianco ML, Marchetti P, Navacchia ML, Guh JH, Perrone D, Hsu LC. Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells. Front Pharmacol 2020;11:599067. [PMID: 33343369 DOI: 10.3389/fphar.2020.599067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
12 Zhou D, Jiang L, Jin L, Yao Y, Wang P, Zhu X. Glucose Transporter-1 Cooperating with AKT Signaling Promote Gastric Cancer Progression. Cancer Manag Res 2020;12:4151-60. [PMID: 32581586 DOI: 10.2147/CMAR.S251596] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
13 Doden HL, Wolf PG, Gaskins HR, Anantharaman K, Alves JMP, Ridlon JM. Completion of the gut microbial epi-bile acid pathway. Gut Microbes 2021;13:1-20. [PMID: 33938389 DOI: 10.1080/19490976.2021.1907271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Kierach R, Dąbrowski K, Grabarek BO, Kojs-Mrożkiewicz M, Boroń D. Is ursodeoxycholic acid therapy due to pregnant intrahepatic cholestasis change the adiponectin and fibroblast growth factor-21 levels?-Pilot study. Dermatol Ther 2020;33:e13296. [PMID: 32149445 DOI: 10.1111/dth.13296] [Reference Citation Analysis]
15 Dalpiaz A, Paganetto G, Botti G, Pavan B. Cancer stem cells and nanomedicine: new opportunities to combat multidrug resistance? Drug Discov Today 2020;25:1651-67. [PMID: 32763499 DOI: 10.1016/j.drudis.2020.07.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
16 Lu X, Wu H, Liang Y, Zhang Z, Lv H. Redox-responsive prodrug for improving oral bioavailability of paclitaxel through bile acid transporter-mediated pathway. Int J Pharm 2021;600:120496. [PMID: 33746013 DOI: 10.1016/j.ijpharm.2021.120496] [Reference Citation Analysis]
17 Peng Y, Nie Y, Yu J, Wong CC. Microbial Metabolites in Colorectal Cancer: Basic and Clinical Implications. Metabolites 2021;11:159. [PMID: 33802045 DOI: 10.3390/metabo11030159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Huang F. Ursodeoxycholic acid as a potential alternative therapeutic approach for neurodegenerative disorders: Effects on cell apoptosis, oxidative stress and inflammation in the brain. Brain Behav Immun Health 2021;18:100348. [PMID: 34632427 DOI: 10.1016/j.bbih.2021.100348] [Reference Citation Analysis]
19 Hersi F, Elgendy SM, Al Shamma SA, Atell RT, Sadiek O, Omar HA. Cancer immunotherapy resistance: The impact of microbiome-derived short-chain fatty acids and other emerging metabolites. Life Sciences 2022. [DOI: 10.1016/j.lfs.2022.120573] [Reference Citation Analysis]
20 Fu J, Yu M, Xu W, Yu S. Research Progress of Bile Acids in Cancer. Front Oncol 2022;11:778258. [DOI: 10.3389/fonc.2021.778258] [Reference Citation Analysis]
21 Zeng Z, Ma C, Chen K, Jiang M, Vasu R, Liu R, Zhao Y, Zhang H. Roles of G Protein-Coupled Receptors (GPCRs) in Gastrointestinal Cancers: Focus on Sphingosine 1-Shosphate Receptors, Angiotensin II Receptors, and Estrogen-Related GPCRs. Cells 2021;10:2988. [PMID: 34831211 DOI: 10.3390/cells10112988] [Reference Citation Analysis]
22 Yang Y, Liu S, Gao H, Wang P, Zhang Y, Zhang A, Jia Z, Huang S. Ursodeoxycholic acid protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction through acting on ALDH1L2. Free Radic Biol Med 2020;152:821-37. [PMID: 32004633 DOI: 10.1016/j.freeradbiomed.2020.01.182] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
23 Doden HL, Ridlon JM. Microbial Hydroxysteroid Dehydrogenases: From Alpha to Omega. Microorganisms 2021;9:469. [PMID: 33668351 DOI: 10.3390/microorganisms9030469] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
24 Thibaut MM, Gillard J, Dolly A, Roumain M, Leclercq IA, Delzenne NM, Muccioli GG, Bindels LB. Bile Acid Dysregulation Is Intrinsically Related to Cachexia in Tumor-Bearing Mice. Cancers (Basel) 2021;13:6389. [PMID: 34945009 DOI: 10.3390/cancers13246389] [Reference Citation Analysis]
25 Huang J, Wen F, Huang W, Bai Y, Lu X, Shu P. Identification of hub genes and discovery of promising compounds in gastric cancer based on bioinformatics analysis. Biomark Med 2020;14:1069-84. [PMID: 32969243 DOI: 10.2217/bmm-2019-0608] [Reference Citation Analysis]
26 Grobe S, Badenhorst CPS, Bayer T, Hamnevik E, Wu S, Grathwol CW, Link A, Koban S, Brundiek H, Großjohann B, Bornscheuer UT. Engineering Regioselectivity of a P450 Monooxygenase Enables the Synthesis of Ursodeoxycholic Acid via 7β-Hydroxylation of Lithocholic Acid. Angew Chem Int Ed Engl 2021;60:753-7. [PMID: 33085147 DOI: 10.1002/anie.202012675] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
27 Medina-Jiménez AK, Monroy-Torres R. Repurposing Individualized Nutritional Intervention as a Therapeutic Component to Prevent the Adverse Effects of Radiotherapy in Patients With Cervical Cancer. Front Oncol 2020;10:595351. [PMID: 33364195 DOI: 10.3389/fonc.2020.595351] [Reference Citation Analysis]
28 di Gregorio MC, Cautela J, Galantini L. Physiology and Physical Chemistry of Bile Acids. Int J Mol Sci 2021;22:1780. [PMID: 33579036 DOI: 10.3390/ijms22041780] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
29 Ashrafizaveh S, Ashrafizadeh M, Zarrabi A, Husmandi K, Zabolian A, Shahinozzaman M, Aref AR, Hamblin MR, Nabavi N, Crea F, Wang Y, Ahn KS. Long non-coding RNAs in the doxorubicin resistance of cancer cells. Cancer Lett 2021;508:104-14. [PMID: 33766750 DOI: 10.1016/j.canlet.2021.03.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
30 Nazmy EA, Helal MG, Said E. Nifuroxazide mitigates cholestatic liver injury by synergistic inhibition of Il-6/Β-catenin signaling and enhancement of BSEP and MDRP2 expression. Int Immunopharmacol 2021;99:107931. [PMID: 34247051 DOI: 10.1016/j.intimp.2021.107931] [Reference Citation Analysis]
31 Marchesi E, Bovolenta M, Preti L, Capobianco ML, Mamchaoui K, Bertoldo M, Perrone D. Synthesis and Exon-Skipping Properties of a 3'-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach. Molecules 2021;26:7662. [PMID: 34946743 DOI: 10.3390/molecules26247662] [Reference Citation Analysis]